Get the tools used by (smart)2 investors.

Relative Strength Index (14d) for Iteos Therapeutics Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

ITOS: Iteos Therapeutics Inc

iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company’s lead antibody pro...

5.39 USD
Price
USD
Fair Value
Upside
5.32 - 18.75
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Iteos Therapeutics Inc's Relative Strength Index (14d):

ITOSHLTH.USDYAIONCOCRDFGERNTRVN0.0010.0020.0030.0040.00

Performance Summary
  • Iteos Therapeutics Inc's relative strength index (14d) is 24.95

How does Iteos's Relative Strength Index (14d) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Iteos Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Relative Strength Index (14d)

Hide this widget
rsi_14d
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Relative Strength Index (14d) in the valuation category include:

  • MACD (12d, 26d) - Illustrates the relationship between two moving averages, aiding in the identification of trend directions and reversals.
  • Price % of 52 Week High, Current - The current stock price expressed as a percentage of the 52 week high, including the current trading session
  • Technial Signal (1w) - This summary metric aggregates various technical indicators over the past one week to produce a comprehensive market signal. The value, which can be Strong Sell, Sell, Neutral, Buy, or Strong Buy, synthesizes the analysis of multiple technical signals, offering a consolidated outlook on short-term market movements.
  • Price % of 52 Week High - The current stock price expressed as a percentage of the 52 week high.
View Full List

Search for metric or datapoint

Relative Strength Index (14d)

A momentum oscillator that measures the speed and change of price movements.

Definition of Relative Strength Index (14d)

Hide this widget

No data available

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
16.5541.5566.55100.9604080120

The chart above depicts the distribution of relative strength index (14d) for companies operating in the Healthcare sector in the Developed economic region. Over 2,580 companies were considered in this analysis, and 2,535 had meaningful values. The average relative strength index (14d) of companies in the sector is 42.99 with a standard deviation of 16.29.

Iteos Therapeutics Inc's Relative Strength Index (14d) of 24.95 ranks in the 9.1% percentile for the sector. The following table provides additional summary stats:

Relative Strength Index (14d) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,587
Included Constituents2,535
Min15.65
Max100.00
Median40.76
Mean42.99
Standard Deviation16.29

You can find companies with similar relative strength index (14d) using this stock screener.

All rights reserved. Terms Of Use